Clinical Trial: A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Brief Summary: A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Detailed Summary:
Sponsor: Abbott
Current Primary Outcome: The primary efficacy variable will be the change from Day 1 to last day of dosing in pH adjusted, serum ionized calcium levels.
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Abbott
Dates:
Date Received: January 27, 2003
Date Started: January 2002
Date Completion:
Last Updated: July 31, 2006
Last Verified: July 2006